Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 55201-55250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04765137
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
PHASE2Recruiting
20 participants
Started: May 21, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04917796
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
NARecruiting
250 participants
Started: May 21, 2021 · Completed: Apr 24, 2026
6 conditions2 sponsors6 locations
NCT04892537
Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance
NARecruiting
50 participants
Started: May 21, 2021 · Completed: Jan 31, 2024
1 condition3 sponsors5 locations
NCT04859335
Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma
NARecruiting
50 participants
Started: May 21, 2021 · Completed: Dec 1, 2028
1 condition1 sponsor1 location
NCT05027529
ECMOsorb Trial - Impact of a VA-ECMO in Combination with CytoSorb in Critically Ill Patients with Cardiogenic Shock
NARecruiting
54 participants
Started: May 21, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05003583
Effects of Emotional Processes on Speech Motor Control in Early Childhood Stuttering.
NARecruiting
50 participants
Started: May 21, 2021 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT04877275
ATG-010(Selinexor) in Combination With Chemotherapy in RRMM
PHASE2Recruiting
50 participants
Started: May 21, 2021 · Completed: Dec 30, 2024
1 condition1 sponsor5 locations
NCT04864145
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
NARecruiting
210 participants
Started: May 21, 2021 · Completed: May 30, 2031
1 condition1 sponsor1 location
NCT04503395
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
NARecruiting
204 participants
Started: May 21, 2021 · Completed: Jun 1, 2028
1 condition2 sponsors32 locations
NCT04859465
Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma
PHASE2Recruiting
69 participants
Started: May 21, 2021 · Completed: Nov 20, 2024
1 condition1 sponsor1 location
NCT04522596
Effect of Dual Bronchodilation With Umeclidinium/Vilanterol on Patients With COPD, Hyperinflation and Heart Failure
PHASE4Recruiting
60 participants
Started: May 21, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT04837365
Impact of Neuropsychological Disorders in Multiple Sclerosis
NARecruiting
20 participants
Started: May 21, 2021 · Completed: May 31, 2026
1 condition1 sponsor3 locations
NCT05714124
Liver Embolization Approaches for Tumor Management
N/ARecruiting
580 participants
Started: May 21, 2021 · Completed: Dec 31, 2031
7 conditions1 sponsor1 location
NCT06596252
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
PHASE3Recruiting
308 participants
Started: May 21, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor12 locations
NCT04586959
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
NARecruiting
278 participants
Started: May 21, 2021 · Completed: Oct 31, 2027
1 condition2 sponsors5 locations
NCT05752214
Quality of Life in Italian Visually Impaired Patients
N/ARecruiting
500 participants
Started: May 20, 2021 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT04570423
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
PHASE2Recruiting
40 participants
Started: May 20, 2021 · Completed: Oct 31, 2027
2 conditions1 sponsor4 locations
NCT04763447
Short Treatment with Omalizumab for Severe Asthma
PHASE4Recruiting
234 participants
Started: May 20, 2021 · Completed: May 20, 2027
1 condition1 sponsor1 location
NCT04689646
Mind Body Syndrome Therapy for Chronic Pain
NARecruiting
150 participants
Started: May 20, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT04899765
Measles and BCG Vaccines for Mother and Child
PHASE4Recruiting
2,400 participants
Started: May 20, 2021 · Completed: Dec 31, 2027
4 conditions3 sponsors1 location
NCT05109819
Esophagus-sparing Radiotherapy for Metastatic Spinal Cord Compression.
NARecruiting
200 participants
Started: May 20, 2021 · Completed: May 31, 2024
4 conditions4 sponsors2 locations
NCT05830591
Gut-oral Axis Microbiome in Autism Spectrum Disorders
N/ARecruiting
86 participants
Started: May 20, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06823401
Study Investigating Anti-drug Antibodies in NSCLC Patients Exposed to Checkpoint Inhibitors (IMB)
N/ARecruiting
270 participants
Started: May 20, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT04848519
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
PHASE2Recruiting
24 participants
Started: May 20, 2021 · Completed: Jan 1, 2027
14 conditions2 sponsors1 location
NCT05208541
Advancing Dignity, Health, and Optimism in Connection With Long Acting Injectables
N/ARecruiting
200 participants
Started: May 20, 2021 · Completed: May 20, 2026
1 condition17 sponsors1 location
NCT04801797
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
PHASE2Recruiting
172 participants
Started: May 20, 2021 · Completed: Jan 1, 2028
1 condition2 sponsors9 locations
NCT05091255
Cryotherapy in the Treatment of Desmoid Tumors
NARecruiting
94 participants
Started: May 20, 2021 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT04604782
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
PHASE1/PHASE2Recruiting
54 participants
Started: May 20, 2021 · Completed: Dec 31, 2026
2 conditions2 sponsors5 locations
NCT04892251
Ketamine Assisted Psychotherapy for Opioid Use Disorder
PHASE1/PHASE2Recruiting
60 participants
Started: May 20, 2021 · Completed: May 30, 2024
1 condition1 sponsor1 location
NCT04800601
Walking Ankle isoKinetic Exercise
NARecruiting
60 participants
Started: May 20, 2021 · Completed: May 20, 2026
1 condition1 sponsor7 locations
NCT04483206
Personalized Autologous Transplant for Multiple Myeloma
PHASE1Recruiting
90 participants
Started: May 20, 2021 · Completed: Dec 31, 2026
1 condition3 sponsors2 locations
NCT04956068
PIPAC for Peritoneal Metastases
PHASE1Recruiting
25 participants
Started: May 20, 2021 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT06669013
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas
PHASE3Recruiting
40 participants
Started: May 20, 2021 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location
NCT04250454
Early Intervention in Infants With Cerebral Palsy
NARecruiting
36 participants
Started: May 20, 2021 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT04701476
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
PHASE2Recruiting
110 participants
Started: May 20, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors3 locations
NCT05620030
Prospective Evaluation of Univentricular Hearts
NARecruiting
30 participants
Started: May 20, 2021 · Completed: May 20, 2041
1 condition1 sponsor1 location
NCT06367517
Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)
N/ARecruiting
30 participants
Started: May 20, 2021 · Completed: May 20, 2026
3 conditions1 sponsor1 location
NCT04897269
Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day
PHASE3Recruiting
824 participants
Started: May 20, 2021 · Completed: Jun 20, 2024
1 condition1 sponsor1 location
NCT04745871
Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).
NARecruiting
159 participants
Started: May 20, 2021 · Completed: May 20, 2027
1 condition1 sponsor1 location
NCT04582487
Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL
NARecruiting
32 participants
Started: May 19, 2021 · Completed: May 31, 2024
4 conditions1 sponsor10 locations
NCT04902846
Immune Checkpoint Inhibitors Nephrotoxicity
N/ARecruiting
220 participants
Started: May 19, 2021 · Completed: Dec 30, 2030
2 conditions4 sponsors2 locations
NCT04850274
Using Re-inforcement Learning to Automatically Adapt a Remote Therapy Intervention (RTI) for Reducing Adolescent Violence Involvement
NARecruiting
750 participants
Started: May 19, 2021 · Completed: Mar 31, 2026
4 conditions2 sponsors4 locations
NCT04891510
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
NARecruiting
135 participants
Started: May 19, 2021 · Completed: Jan 31, 2027
3 conditions1 sponsor1 location
NCT04903899
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
PHASE2Recruiting
24 participants
Started: May 19, 2021 · Completed: May 20, 2031
2 conditions3 sponsors5 locations
NCT06312748
Novel Approaches for Improving Vascular Function in Veterans With HFpEF
PHASE1Recruiting
90 participants
Started: May 19, 2021 · Completed: Sep 30, 2030
2 conditions2 sponsors1 location
NCT04811560
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
PHASE1/PHASE2Recruiting
400 participants
Started: May 19, 2021 · Completed: May 26, 2028
3 conditions1 sponsor99 locations
NCT04874428
Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis
PHASE1Recruiting
24 participants
Started: May 19, 2021 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06774482
Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms
N/ARecruiting
3,000 participants
Started: May 19, 2021 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT04766554
Cerebral Oxygen Saturation Monitoring In Cardiac Surgery (COSMICS)
NARecruiting
326 participants
Started: May 19, 2021 · Completed: Jul 20, 2024
2 conditions1 sponsor2 locations
NCT04800458
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
NARecruiting
225 participants
Started: May 19, 2021 · Completed: May 31, 2027
3 conditions2 sponsors1 location